| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 11 |
| 1 | ADALIMUMAB | 7 |
| 2 | METHOTREXATE | 5 |
| 3 | METHOTREXATE SODIUM | 5 |
| 4 | FUROSEMIDE | 4 |
| 5 | LEUPROLIDE ACETATE | 4 |
| 6 | CARBOPLATIN | 3 |
| 7 | GEMCITABINE | 3 |
| 8 | GEMCITABINE HYDROCHLORIDE | 3 |
| 9 | NIVOLUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DUVELISIB | 2 | 0.0023 |
| 1 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 2 | DACOMITINIB | 1 | 0.0013 |
| 3 | LASMIDITAN | 1 | 0.0009 |
| 4 | ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE | 1 | 0.0006 |
| 5 | METHYLENE BLUE | 1 | 0.0006 |
| 6 | DECITABINE | 2 | 0.0005 |
| 7 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| 8 | BRIGATINIB | 1 | 0.0003 |
| 9 | PHENAZOPYRIDINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 12 | 0.0001 |
| 7 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |